S5
6.21 mmol) and potassium tert-butoxide (1.68 g, 14.9 mmol). The solution was allowed to stir for 1 h at ambient temperature. 3-Methoxy-2-nitrobenzaldehyde (1.07 g, 5.91 mmol) was added dropwise to the reaction mixture in anhydrous THF (5 mL), which was allowed to stir for 12 h at ambient temperature. The solution was quenched with 2 M HCl (20 mL), and the organic solvent was evaporated under reduced pressure. The aqueous phase was extracted with EtOAc (4 x 30 mL), washed with brine, dried over Na 2 SO 4 , filtered, evaporated under reduced pressure, and purified by flash chromatography with a prepacked 100 g silica gel column [eluents; solvent A, EtOAc, solvent B, hexanes; gradient, 10% A/90% B 12% A/88% B (1 CV), 12% A/88% B 100% A/0% B (13 CV), 100% A/0% B (1.5 CV); flow rate, 40 mL/min; monitored at λ's 254 and 280 nm]. Pentenoic acid analogue 8 (0.879 g, 3.46 mmol, 58% yield) was obtained as a mixture of E and Z isomers that was a red solid, R f = 0.16 (50:50 hexanes:EtOAc). 1, 178.0, 150.76, 150.74, 134.8, 134.3, 130.62, 130.60, 123.6, 123.5, 121.6, 118.0, 111.2, 110.9, 56.41, 56.39, 33.4, 33.1, 28.0, 23.8 .
H NMR (CDCl

HRMS, m/z: observed 252.0868 [M + H]
+ , (calcd for C 12 H 14 NO 5 + , 252.0866).
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S6 5-(3-Methoxy-2-nitrophenyl)pentanoic acid (9): Pentenoic acid analogue 8 (2.06 g, 8.21 mmol) under N 2 was added to anhydrous MeOH (100 mL) under N 2 . To this solution was added 10% Pd/C (2.00 g) and stirred for 10 min at ambient temperature.
1,4-Cyclohexadiene (16.4 g, 205 mmol) was added to the mixture, which was stirred for 4 h. The reaction mixture was filtered through celite, washed with EtOAc (4 x 25 mL), evaporated under reduced pressure, and purified by flash chromatography using 20%
EtOAc/80% hexanes as eluent. Pentanoic acid analogue 9 was obtained as a tan solid (1.54 g, 6.10 mmol, 74% yield), R f = 0. 4, 150.7, 141.8, 134.7, 130.7, 121.6, 110.1, 56.3, 33.6, 30.6, 29.7, 24 containing pentanoic acid analogue 9 (0.281 g, 1.11 mmol) was added 5.5 mL of Eaton's reagent (7.7% P 2 O 5 in CH 3 SO 3 H). The solid slowly dissolved with vigorous stirring and was allowed to stir for 12 h at ambient temperature. The solution was poured over ice, which was allowed to melt, then slowly neutralized with NaHCO 3 (aq.). The aqueous phase was extracted with EtOAc (4 x 25 mL). The combined organic extracts were washed with brine, dried over Na 2 SO 4 , filtered, evaporated under reduced pressure, and purified using flash chromatography with a prepacked 25 g silica column [eluents; 149.4, 142.4, 140.4, 138.5, 137.7, 133.5, 129.3, 109.2, 104.0, 79.7, 60.9, 56.2, 56.2, 40.9, 28.6, 26.3, 25. 149.3, 141.5, 141.5, 137.7, 137.3, 134.9, 133.7, 131.8, 128.6, 109.7, 105.1, 60.9, 56.3, 56.2, 34.7, 27.3, 25 8, 146.3, 143.5, 138.6, 137.2, 133.6, 132.4, 126.8, 126.3, 119.8, 107.6, 105.3, 60.9, 56.1, 55.6, 33.2, 25.6, 25. 38, 179.35, 172.01, 159.74, 159.56, 159.42, 138.72, 138.46, 131.07, 130.53, 130.31, 130.16, 129.51, 129.48, 129.23, 128.35, 122.64, 121.20, 120.48, 118.76, 114.30, 114.23, 112.84, 112.38, 111.44, 77.29, 77.03, 76.78, 55.44, 55.19, 34.13, 33.75, 27.86, 23.80 . (1.50 g, 7.27 mmol) in MeOH (20 mL) was stirred under H 2 gas for 24 h. The reaction was checked for completion by filtering a little amount of the reaction mixture through celite and evaporating the solvent to record NMR data. On completion the reaction mixture was filtered through celite and the solvent was evaporated under reduced pressure to obtain a pale yellow liquid. 89, 159.60, 143.65, 129.29, 120.82, 114.16, 111.06, 77.28, 77.03, 76.77, 55.14, 35.56, 30.64, 24 .28.
HRMS,
2-Methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one (15) S1 : Eaton's reagent (60.0 g) was added to compound 14 (3.01 g, 14.5 mmol) and the solution was stirred for 12 h under N 2 . The reaction mixture was poured over ice and the ice was allowed to melt.
The aqueous phase was extracted with CH 2 Cl 2 (2 × 100 mL) and the combined organic phase was washed with NaHCO 3 (Satd. soln.) (2 × 100 mL). The organic phase was dried over Na 2 SO 4 and the solvent was evaporated under reduced pressure to obtain a pale Purity by HPLC: R f = 10.65 min, 95% at 254, and 280 nM. 4, 152.9, 143.4, 139.2, 138.9, 137.8, 135.8, 132.0, 129.0, 118.1, 110.7, 106.6, 61.2, 57.0, 56.6, 34.9, 26.8, 26 Calculated based on protonated free amine].
3-Methoxy-4-nitro-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5H-benzo[7]annulene
Purity by HPLC: R f = 8.12 min, 98% at 254, and 280 nM.
Biology:
Effects on Tubulin Polymerization. Bovine brain tubulin was purified using methods previously described. S3 The effect of compounds on tubulin assembly in vitro was determined by using a series of concentrations that were preincubated with 10 µM tubulin (1.0 mg/mL) in glutamate buffer at 30 °C, followed by cooling to 0 °C. After GTP was added, the samples were mixed and transferred to cuvettes at 0 °C in a recording spectrophotometer and warmed to 30 °C to initiate polymerization. Tubulin assembly was observed turbidimetrically at 350 nm. S4 Tubulin disassembly was confirmed by cooling to 0 °C. The calculated compound concentration that inhibited tubulin assembly by 50% after a 20 min incubation was defined as the IC 50 value. 
S20
Gentamycin Sulfate (100 µg/mL, Teknova Inc., Hollister, CA), Amphotericin B (0.25 µg/mL, Mediatech Inc., Manassas, VA) and a low serum growth supplement (50x, 10 mL, Gibco®, Grand Island, NY) containing fetal bovine serum (2%), hydrocortisone (1 µg⁄ml), human epidermal growth factor (10 ng⁄ml), basic fibroblast growth factor (3 ng⁄ml), and heparin (10 µg⁄ml). Cells were removed from the culture flask by treatment with a trypsin/ EDTA solution (1x, 3 mL, Gibco®, Grand Island, NY) followed by pug.pdf
